Metastatic Papillary Thyroid Carcinoma With Adjacent BRAF (V600E)-Mutated Squamous Cell Carcinoma

被引：2
|
作者：
Rupani, Asha [1 ]
Hughes, Owain R. [1 ]
Watkinson, John [1 ]
Nutting, Christopher M.
Thway, Khin [1 ]
机构：
[1] Royal Marsden Hosp, London, England
来源：
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY | 2017年 / 25卷 / 03期
关键词：
TUMOR;
D O I：
10.1177/1066896916674811
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：243 / 245
页数：3
相关论文
共 50 条
  • [41] BRAF V600E mutational analysis of metastatic lymph nodes from two Tunisian females with papillary thyroid carcinoma
    Turki, F.
    Aloulou, S.
    Trabelsi, O.
    Charfi, S.
    Chakroun, A.
    Achour, I.
    Abdellaoui, N.
    Louati, R.
    Kaabi, Y.
    Smaoui, W.
    Fourati, H.
    Chaker, K.
    Trigui, K.
    Ben Aziza, M.
    Ltaif, W.
    Denguir, H.
    Ben Ameur, H.
    Mallek, S.
    Aloulou, W.
    Jabeur, J.
    Dammak, J.
    Mrabet, S.
    Kammoun, S.
    Mzid, F.
    Kammoun, W.
    Bedoui, O.
    Kaabi, A.
    Mhiri, N.
    Maalla, N.
    Ghorbel, A.
    Boudawara, T.
    Bouayed, N. Abdelmoula
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 594 - 594
  • [42] Genomic profiling and outcomes of BRAF V600E mutated papillary thyroid cancer.
    Shaikh, Hira
    McGrath, Julie
    Brodskiy, Pavel
    Xiu, Joanne
    Ikpeazu, Chukwuemeka
    Leddon, Jennifer
    Sukari, Ammar
    Zandberg, Dan Paul
    Abraham, Jim
    Wise-Draper, Trisha Michel
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18086 - E18086
  • [43] BRAF V600E in Pediatric Papillary Thyroid Carcinomas
    Paulson, V. A.
    Hollowell, M. L.
    Huang, S. A.
    Barletta, J. A.
    LABORATORY INVESTIGATION, 2014, 94 : 157A - 157A
  • [44] Morphology predicts BRAF V600E mutation in papillary thyroid carcinoma: an interobserver reproducibility study
    Virk, Renu K.
    Theoharis, Constantine G. A.
    Prasad, Avinash
    Chhieng, David
    Prasad, Manju L.
    VIRCHOWS ARCHIV, 2014, 464 (04) : 435 - 442
  • [45] BRAF V600E Mutation Lacks Association with Poorer Clinical Prognosis in Papillary Thyroid Carcinoma
    Hon-Fan Lai
    Jen-Fan Hang
    Po-Chung Kuo
    Chin-Sung Kuo
    San-Fan Yao
    Jui-Yu Chen
    Chen-Hsen Lee
    Annals of Surgical Oncology, 2024, 31 : 3495 - 3501
  • [46] The BRAF V600E Mutation in Papillary Thyroid Carcinoma Is Associated with Glucose Transporter 1 Overexpression
    Grabellus, Florian
    Worm, Karl
    Schmid, Kurt Werner
    Sheu, Sien-Yi
    THYROID, 2012, 22 (04) : 377 - 382
  • [47] Vemurafenib selectively radiosensitizes BRAF V600E mutant papillary and anaplastic thyroid carcinoma cells
    Robb, Ryan N.
    Yang, Linlin
    Williams, Terence
    CANCER RESEARCH, 2017, 77
  • [48] Clinical utility of immunohistochemistry for the detection of the BRAF v600e mutation in papillary thyroid carcinoma DISCUSSION
    Yip, Linwah
    Zagzag, Jonathan
    Moo-Young, Tricia A.
    Nilubol, Naris
    Sippel, Rebecca S.
    Solorzano, Carmen C.
    Parangi, Sareh
    SURGERY, 2013, 154 (06) : 1204 - 1205
  • [49] Immunohistochemistry is a feasible method to screen BRAF V600E mutation in colorectal and papillary thyroid carcinoma
    Zhang, Xiangyan
    Wang, Lili
    Wang, Jigang
    Zhao, Han
    Wu, Jie
    Liu, Shuhong
    Zhang, Lu
    Li, Yujun
    Xing, Xiaoming
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2018, 105 (01) : 153 - 159
  • [50] BRAF V600E Mutation and Papillary Thyroid Cancer
    Ciarrocchi, Alessia
    Cavuto, Silvio
    Piana, Simonetta
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (05): : 534 - 534
12345